Inflammation of the thyroid gland with multiple aetiologies. Subacute (de Quervain) thyroiditis presents with painful thyroid and transient thyrotoxicosis. Postpartum thyroiditis affects ~5% of women. Hashimoto thyroiditis is covered under hypothyroidism.

Key Facts

Subacute (de Quervain) thyroiditis
viral aetiology; painful tender thyroid + fever + raised ESR; transient thyrotoxicosis
hypothyroidism
recovery; self-limiting over 2-4 months
Postpartum thyroiditis
~5% of postpartum women; painless; thyrotoxicosis (1-6 months postpartum)
hypothyroidism (3-12 months)
recovery (~80%); associated with anti-TPO antibodies
  • Silent (painless) thyroiditis: similar to postpartum but unrelated to pregnancy; autoimmune; transient
  • Thyroid uptake scan: LOW/absent uptake in all thyroiditis (distinguishes from Graves/toxic nodule where uptake is increased)
  • No antithyroid drugs for thyrotoxic phase of thyroiditis (destructive release of preformed hormone - not new synthesis); use beta-blockers for symptom control
  • Subacute thyroiditis treatment: NSAIDs (ibuprofen 400mg TDS) or prednisolone 30-40mg/day tapering over 6-8 weeks if severe

Overview

Key Facts

Thyroiditis encompasses several inflammatory conditions with different aetiologies but a common pattern of transient thyroid hormone release. The uptake scan showing low uptake is key to distinguishing thyroiditis from other causes of thyrotoxicosis.

Epidemiology

Subacute thyroiditis: incidence ~5 per 100,000/year; F:M 3:1; peak age 30-50. Postpartum thyroiditis: ~5-10% of postpartum women. Hashimoto: commonest cause of hypothyroidism (covered separately).

Aetiology

Subacute: presumed viral (often post-URTI; coxsackievirus, adenovirus, mumps). HLA-B35 association. Postpartum/silent: autoimmune (anti-TPO positive). Drug-induced: amiodarone (type 2), checkpoint inhibitors, lithium.

Pathophysiology

Thyroiditis causes destruction of thyroid follicular cells
release of preformed T4 and T3 into circulation (thyrotoxic phase). As stores are depleted and the gland is damaged
hypothyroid phase. Most recover as inflammation resolves and thyroid regenerates, but some develop permanent hypothyroidism.

Clinical Presentation

Subacute (de Quervain) Thyroiditis

  • Painful, tender, firm thyroid (often unilateral initially, migrating)
  • Systemic: fever, malaise, myalgia
  • Thyrotoxic phase (weeks 1-4): palpitations, weight loss, tremor
  • Hypothyroid phase (weeks 4-12): fatigue, weight gain
  • Recovery phase: euthyroid by 3-6 months (~95% recover fully)
  • Preceded by viral URTI in 2-8 weeks

Postpartum Thyroiditis

  • 1-6 months postpartum: transient thyrotoxicosis (often mild, may be missed)
  • 3-12 months postpartum: hypothyroid phase (more symptomatic; fatigue, depression, weight gain)
  • ~80% recover; ~20% develop permanent hypothyroidism
  • Associated with anti-TPO antibodies

Red Flags

  • Severe pain unresponsive to NSAIDs → consider acute suppurative thyroiditis (rare, bacterial)
  • Thyrotoxicosis misdiagnosed as Graves → antithyroid drugs are ineffective and inappropriate

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
Graves diseasePainless diffuse goitre, TRAb+, high uptakeTRAb, uptake scan
Toxic multinodular goitrePainless, nodular, elderlyUSS, uptake scan
Acute suppurative thyroiditisExquisitely tender, fever, abscessUSS, FNA, cultures
Thyroid lymphomaRapid painless growth, Hashimoto backgroundCore biopsy
Pharyngitis/neck infectionSore throat, cervical lymphadenopathyExamination, throat swab

Diagnosis / Investigation

Bloods

  • TFTs: thyrotoxic phase (suppressed TSH, raised T4/T3); hypothyroid phase (raised TSH, low T4)
  • ESR/CRP: markedly raised in subacute thyroiditis (ESR often >50)
  • Anti-TPO: positive in postpartum/silent thyroiditis; may be positive in subacute
  • TRAb: negative (distinguishes from Graves)

Imaging

  • Thyroid uptake scan: low/absent uptake in thyrotoxic phase - KEY diagnostic feature (vs diffuse high uptake in Graves)
  • USS thyroid: diffuse hypoechogenicity; may show focal areas of inflammation

Management

Subacute Thyroiditis

  • Thyrotoxic phase: beta-blockers (propranolol 40-80mg TDS) for symptom control; NO antithyroid drugs
  • Pain: NSAIDs (ibuprofen 400mg TDS, naproxen 500mg BD); if insufficient: prednisolone 30-40mg/day, taper over 4-8 weeks
  • Hypothyroid phase: levothyroxine if symptomatic (temporary - reassess at 6-12 months)
  • Recovery: most euthyroid by 3-6 months; ~5% develop permanent hypothyroidism

Postpartum Thyroiditis

  • Thyrotoxic phase: beta-blockers if symptomatic; NO antithyroid drugs
  • Hypothyroid phase: levothyroxine if symptomatic or planning pregnancy (may be temporary)
  • Monitoring: TFTs every 4-8 weeks during active phases
  • Long-term: annual TFTs (20% develop permanent hypothyroidism)

Referral Criteria

  • Endocrinology: diagnostic uncertainty, severe thyroiditis, recurrent episodes

Prognosis

Subacute thyroiditis: self-limiting; ~95% recover full thyroid function by 6-12 months; ~5% permanent hypothyroidism; recurrence rare (~2%). Postpartum thyroiditis: ~80% recover; ~20% permanent hypothyroidism (higher if anti-TPO positive, higher titres). Postpartum thyroiditis recurs in ~70% of subsequent pregnancies.

Other Relevant Information

Thyroiditis - Typical Triphasic Course

PhaseDurationTFTsSymptoms
Thyrotoxic1-8 weeksLow TSH, high T4Palpitations, weight loss
Hypothyroid4-12 weeksHigh TSH, low T4Fatigue, weight gain
Recovery3-12 monthsNormalEuthyroid

Thyroid Uptake Scan Patterns

ConditionUptake
Graves diseaseDiffuse HIGH
Toxic MNGPatchy HIGH
Toxic adenomaSingle HOT nodule
Subacute thyroiditisLOW/absent
Postpartum thyroiditisLOW/absent
Thyrotoxicosis factitiaLOW/absent